- Home
- NERV vs FLGC Comparison
NERV vs FLGC Comparison
Compare NERV & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- FLGC
- Stock Information
- Founded
- NERV 2007
- FLGC 2019
- Country
- NERV United States
- FLGC United States
- Employees
- NERV N/A
- FLGC N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- NERV Health Care
- FLGC Health Care
- Exchange
- NERV Nasdaq
- FLGC Nasdaq
- Market Cap
- NERV 14.6M
- FLGC 13.5M
- IPO Year
- NERV 2014
- FLGC 2021
- Fundamental
- Price
- NERV $2.83
- FLGC $19.23
- Analyst Decision
- NERV Hold
- FLGC Strong Buy
- Analyst Count
- NERV 1
- FLGC 1
- Target Price
- NERV $5.00
- FLGC $156.00
- AVG Volume (30 Days)
- NERV 639.5K
- FLGC 108.1K
- Earning Date
- NERV 11-04-2025
- FLGC 11-12-2025
- Dividend Yield
- NERV N/A
- FLGC N/A
- EPS Growth
- NERV N/A
- FLGC N/A
- EPS
- NERV 1.48
- FLGC N/A
- Revenue
- NERV N/A
- FLGC $52,373,000.00
- Revenue This Year
- NERV N/A
- FLGC N/A
- Revenue Next Year
- NERV N/A
- FLGC $10.22
- P/E Ratio
- NERV $1.47
- FLGC N/A
- Revenue Growth
- NERV N/A
- FLGC N/A
- 52 Week Low
- NERV $1.15
- FLGC $15.15
- 52 Week High
- NERV $3.29
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- NERV 70.41
- FLGC N/A
- Support Level
- NERV $2.06
- FLGC N/A
- Resistance Level
- NERV $2.15
- FLGC N/A
- Average True Range (ATR)
- NERV 0.11
- FLGC 0.00
- MACD
- NERV 0.02
- FLGC 0.00
- Stochastic Oscillator
- NERV 70.72
- FLGC 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.